IMARC Group has recently released a new research study titled “Human Insulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global human insulin market size reached US$ 45.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 68.0 Billion by 2028, exhibiting a growth rate (CAGR) of 6.48% during 2023-2028.
Human insulin (HI) is a short-acting insulin that is synthesized in laboratories. Commonly utilized to mimic the function of natural insulin present in humans, it is bio-engineered by growing insulin proteins within E-coli bacteria (Escherichia coli). It is available as a solution and suspension and is required to be injected subcutaneously. It is widely employed for controlling the blood sugar levels of patients with type I and II diabetes. HI functions by aiding the sugar produced by the human body to move from the blood to other body tissues where it is used for energy. It can additionally stop the liver from producing more sugar. Apart from this, HI also assists in inhibiting hepatic glucose production and improving the protein synthesis of the body.
Impact of COVID-19:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Download a free sample report to get a detailed overview of the market: https://www.imarcgroup.com/human-insulin-market/requestsample
Human Insulin Market Trends and Drivers:
The growing prevalence of obesity and diabetes among individuals due to sedentary lifestyles represents one of the key factors driving the market. Apart from this, there is a significant rise in the demand for biosimilar drugs on account of their cost-effectiveness and higher efficiency, which, in turn, is also supporting the growth of the market. Furthermore, the key players are introducing pen devices and safety pen needles for improved delivery of insulin to the body. This, in confluence with the increasing research and development (R&D) activities, is acting as another growth-inducing factor.
Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=1950&flag=C
Human Insulin Market 2023-2028 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product Type:
Breakup by Distribution Channel:
Breakup by Disease Type:
Market Breakup by Region:
Key Highlights of the Report:
If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Trending Reports (Book Now with 10% Discount + COVID-19 Scenario):
Pharmacovigilance Market Forecast
Patient Engagement Solutions Market Size
Contact Lenses Market Trends
Durable Medical Equipment Market Insights
Medical Device Cleaning Market Growth
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
Media ContactCompany Name: IMARC GroupContact Person: Elena AndersonEmail: Send EmailPhone: +1-631-791-1145Address:30 N Gould St Ste R City: SheridanState: WYCountry: United StatesWebsite: https://www.imarcgroup.com